Skip to content

Usefulness of Vitamin D Supplements and its Receptor Genetic variations in sugar patients with Infection of Foot from Southern part of India

Effect of Vitamin D Supplementation and Vitamin D Receptor Gene Polymorphisms in South-Indian Patients with Diabetic Foot Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/09/021029
Enrollment
476
Registered
2019-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E106- Type 1 diabetes mellitus with other specified complications Health Condition 2: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Manipal Center for Infectious Diseases
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both genders 2. Age 18 years or older 3. Patients with type 1 or 2 DM 4. Newly diagnosed foot ulcers 5. IDSA: uninfected. (For DFU patients) 6. IDSA: mild/moderate (For DFI patients) 7. Volunteers without a previous history of DM who has come for regular health check-up or blood donation (healthy controls) 8. Participants willing to give the informed consent form and participate in the study

Exclusion criteria

Exclusion criteria: 1. Individuals with hepatic disease, renal disease, or other comorbidities that can alter vitamin D levels 2. Diagnosis of lower limb critical ischemia by Doppler ultrasound and ankle/arm index less than 0.5 3. Patients with lower limb ulcers with distal necrosis 4. Patients having clinical evidence of vascular insuf�ciency 5. Patients currently on steroid (use in the past 30 days) cytotoxic drugs, immunosuppressants, Calcium supplements, multivitamins, and drugs that could alter vitamin D status 6. Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Clinical Wound Healing Health Related Quality of Life (HRQoL)Timepoint: 4 months

Secondary

MeasureTime frame
Quality of lifeTimepoint: 4 months

Countries

India

Contacts

Public ContactShilia Jacob Kurian

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences

sonal.sekhar@manipal.edu7411338846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026